GGFRX
Price
$16.74
Change
-$0.13 (-0.77%)
Updated
Jul 13 closing price
Net Assets
1.64B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

GGFRX vs VSTSX

GGFRX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
GGFRX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGFRX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. GGFRX (1.64B). VSTSX pays higher dividends than GGFRX: VSTSX (1.07) vs GGFRX (0.33). GGFRX was incepted earlier than VSTSX: GGFRX (23 years) vs VSTSX (10 years). GGFRX (1.27) is less costly to investors than VSTSX (0.01). GGFRX is a more actively managed with annual turnover of: 13.78 vs. VSTSX (3.00). GGFRX has a lower initial minimum investment than VSTSX: GGFRX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. GGFRX (15.10). VSTSX return over 5 years is better than : 66.56 vs. GGFRX (39.63).
GGFRXVSTSXGGFRX / VSTSX
Total Expense Ratio1.250.0112,500%
Annual Report Gross Expense Ratio1.270.0112,700%
Fund Existence23 years10 years-
Gain YTD10.24711.20591%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B2.3T0%
Annual Yield % from dividends0.331.0730%
Returns for 1 year15.1021.4870%
Returns for 3 years51.9267.0677%
Returns for 5 years39.6366.5660%
Returns for 10 years72.63239.5330%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I